Therapeutic Asset Ratings

498 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
HEPARIN Cancer of Liver	H. Lee Moffitt Cancer Center and Research Institute	N/A	D (30)
HEPARIN Cancer of Pancreas	H. Lee Moffitt Cancer Center and Research Institute	N/A	D (30)
HEPARIN Cancer of Stomach	H. Lee Moffitt Cancer Center and Research Institute	N/A	D (30)
HEPARIN Hyperinsulinism	University of Colorado, Denver	N/A	D (30)
HEPARIN Hypogonadotropic Hypogonadism	University of Colorado, Denver	N/A	D (30)
HEPARIN Infertility Disorder	University of Colorado, Denver	N/A	D (30)
L-AMINO ACIDS Acupuncture	University of Crete		D (30)
L-AMINO ACIDS Anal Cancer	D'Or Institute for Research and Education	N/A	D (30)
L-AMINO ACIDS Electroacupuncture	University of Crete		D (30)
L-AMINO ACIDS Fibromyalgia	University of Crete		D (30)
L-AMINO ACIDS Functional Decline	University of Ioannina	N/A	D (30)
L-AMINO ACIDS Hyperalgesia	University of Crete		D (30)
L-AMINO ACIDS Hypercholesterolemia	University of Bologna	N/A	D (30)
L-AMINO ACIDS Hypoalbuminemia	University of Ioannina	N/A	D (30)
L-AMINO ACIDS Malnutrition (Calorie)	University of Ioannina	N/A	D (30)
L-AMINO ACIDS Non-Alcoholic Fatty Liver Disease	University of Copenhagen	N/A	D (30)
L-AMINO ACIDS Nutritional Deficiency	D'Or Institute for Research and Education	N/A	D (30)
L-AMINO ACIDS Osteopenia	University of Ioannina	N/A	D (30)
L-AMINO ACIDS Parkinson Disease (PD)	Medipol University	N/A	D (30)
LANOLIN Breast Carcinoma	OHSU Knight Cancer Institute	N/A	D (30)
LANOLIN Head and Neck Carcinoma	OHSU Knight Cancer Institute	N/A	D (30)
LANOLIN Radiation-Induced Dermatitis	OHSU Knight Cancer Institute	N/A	D (30)
LAVENDER OIL Breast Cancer Patients Receiving Chemotherapy	Setenay Batır	N/A	D (30)
LAVENDER OIL Chronic Rhinosinusitis	Cedars-Sinai Medical Center	N/A	D (30)
LAVENDER OIL Diabetes Mellitus	Nilgün Erdoğan	N/A	D (30)

Showing 376 to 400 of 498 assets

PreviousPage 16 of 20Next